@misc{indiciae2304f5e45e4b,
  title = {Vertical RAS-pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterations},
  author = {Hafner, P. and Keller, S. and Chen, X. and Alrawashdeh, A. and Jumaa, H. and Nollmann, F. and Besson, S. and Kemming, J. and Gorka, O. and Das, T. and Appiah, B. and Lehmann, A. and Li, M. and Apostolova, P. and Bengsch, B. and Tholen, S. and Schilling, O. and Gross, O. and Vlachos, A. and Wittel, U. and von Elverfeldt, D. and Reichardt, W. and Boerries, M. and Andrieux, G. and Heynen, G. and Fichtner-Feigl, S. and Hannibal, L. and Ruess, D.},
  year = {2025},
  doi = {10.1101/2025.02.03.636222},
  url = {https://www.biorxiv.org/content/10.1101/2025.02.03.636222v1},
  note = {Source identifier: 10.1101/2025.02.03.636222}
}